Minoryx Therapeutics
Posted on: November 10, 2022
By: Kim Berlowitz
With: Comments Off on Minoryx Therapeutics
MTS serves as exclusive financial advisor to Minoryx Therapeutics on its exclusive European licensing agreement of Leriglitazone with Neuraxpharm Group